Multani Pratik S — SEC Form 4 filings
SEC reporting owner CIK 1586894. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-21 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 19,570 shares, $170,422 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 10,720 shares @ $9.06 ($97,129) in Oric Pharmaceuticals, Inc., filed 2025-12-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | Chief Medical Officer | 4 | — | 2 legs · 19,570 sh · $170,422 | 12 |
| CHIMERIX INC (CMRX) | Director | 2 | — | — | 7 |
| Erasca, Inc. (ERAS) | Director | 5 | — | — | 6 |
Form 4 filings — Multani Pratik S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 29,888 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 214,000 (derivative) @ $0 · Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 19,532 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 29,333 @ $0 · Sale (S): 10,720 @ $9.06 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 11,333 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Erasca, Inc. (ERAS) | Gift (G): 6,200 @ $0 · Gift (G): 6,200 @ $0 | EDGAR |
| 2025-04-21 | 4 | CHIMERIX INC (CMRX) | Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2025-01-03 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 202,500 (derivative) @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 24,042 @ $0 · Sale (S): 8,850 @ $8.28 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1586894 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →